These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27043043)

  • 1. The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.
    Ratner N; Brodeur GM; Dale RC; Schor NF
    Ann Neurol; 2016 Jul; 80(1):13-23. PubMed ID: 27043043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood opsoclonus myoclonus.
    Dale RC
    Lancet Neurol; 2003 May; 2(5):270. PubMed ID: 12849175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome.
    Swart JF; de Kraker J; van der Lely N
    Eur J Pediatr; 2002 May; 161(5):255-8. PubMed ID: 12012219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
    Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
    Bell J; Moran C; Blatt J
    Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence: treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone.
    Emir S; Akyüz C; Büyükpamukçu M
    Med Pediatr Oncol; 2003 Feb; 40(2):139. PubMed ID: 12461808
    [No Abstract]   [Full Text] [Related]  

  • 10. Late presentation of opsoclonus-myoclonus-ataxia syndrome in a child with stage 4S neuroblastoma.
    Mutch LS; Johnston DL
    J Pediatr Hematol Oncol; 2005 Jun; 27(6):341-3. PubMed ID: 15956891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
    Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
    J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
    Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
    Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature.
    De Luca S; Terrone C; Crivellaro S; De Zan A; Polo P; Vigliani MC; Tizzani A
    Urol Int; 2002; 68(3):206-8. PubMed ID: 11919472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
    Blatt J
    Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroblastoma: an unusual presentation with bilateral ptosis.
    Tatli B; Saribeyoğlu ET; Aydinli N; Calişkan M; Anak S
    Pediatr Neurol; 2004 Apr; 30(4):284-6. PubMed ID: 15087109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
    Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
    Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
    Greensher JE; Louie J; Fish JD
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
    Raffaghello L; Conte M; De Grandis E; Pistoia V
    Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
    Johnston WR; Hwang R; Mattei P
    Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.
    Mitchell WG; Blaes F
    Semin Pediatr Neurol; 2017 Aug; 24(3):180-188. PubMed ID: 29103425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.